Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Core EBITDA Margin

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
   Core EBITDA Margin(%) 15.0216.2513.3714.4511.84

What is the latest Core EBITDA Margin ratio of NATH BIOGENES (INDIA) ?

The latest Core EBITDA Margin ratio of NATH BIOGENES (INDIA) is 15.02 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202415.02
Mar202316.25
Mar202213.37
Mar201314.45
Mar201211.84

How is Core EBITDA Margin of NATH BIOGENES (INDIA) Trending?

Years Core EBITDA Margin % Change
Mar2024 15.02
-7.57
Mar2023 16.25
21.54
Mar2022 13.37
-7.47
Mar2013 14.45
22.04
Mar2012 11.84 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Core EBITDA Margin ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹364.2 Cr 6.4% 3.6% -8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹16,782.6 Cr -4.7% -12.5% 72.5% Stock Analytics
KAVERI SEED COMPANY ₹4,470.6 Cr 3.3% 2.6% 45.7% Stock Analytics
VENKYS (INDIA) ₹2,471.8 Cr 3% 2.3% -12% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,797.7 Cr 21.9% 6.8% -35% Stock Analytics
TIERRA AGROTECH ₹402.7 Cr -1.4% 3.3% -36% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

6.4%

3.6%

-8%

SENSEX

0.9%

-0.3%

20.9%


You may also like the below Video Courses